Abbott Labs Reports Director and Officer Changes
Ticker: ABT · Form: 8-K · Filed: May 1, 2025 · CIK: 1800
| Field | Detail |
|---|---|
| Company | Abbott Laboratories (ABT) |
| Form Type | 8-K |
| Filed Date | May 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-changes, director-changes
Related Tickers: ABT
TL;DR
ABT filed an 8-K on director/officer changes effective 4/25.
AI Summary
Abbott Laboratories filed an 8-K on May 1, 2025, reporting changes effective April 25, 2025. The filing pertains to the departure of directors, election of directors, appointment of officers, and compensatory arrangements for certain officers. Specific details regarding individuals, dollar amounts, and exact dates of these changes are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes and does not indicate immediate financial or operational risks.
Key Players & Entities
- ABBOTT LABORATORIES (company) — Registrant
- April 25, 2025 (date) — Effective date of reported events
- May 1, 2025 (date) — Filing date of the 8-K
FAQ
What specific director positions became vacant or were filled?
The filing indicates the departure of directors and the election of directors, but the specific positions are not detailed in this excerpt.
Who are the newly appointed officers?
The filing mentions the appointment of certain officers, but their names are not provided in this excerpt.
What are the details of the compensatory arrangements for the officers?
The filing notes that compensatory arrangements for certain officers are being reported, but the specific terms and amounts are not included in this excerpt.
What was the exact date of the board and officer changes?
The date of the earliest event reported is April 25, 2025.
What is the company's standard industrial classification?
The company's standard industrial classification is Pharmaceutical Preparations [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 1, 2025 regarding ABBOTT LABORATORIES (ABT).